ChEMBL ligand: CHEMBL1323 ((-)-darunavir, Darunavir, MC-114, Prezista, TMC 114, TMC-114, TMC114, TMC-41629, UIC-94017, UIC-940T)
Kv11.1/HERG in Human [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] There should be some charts here, you may need to enable JavaScript!
Human immunodeficiency virus type 1 protease in Human immunodeficiency virus 1 [ChEMBL: CHEMBL243] [UniProtKB: Q72874] There should be some charts here, you may need to enable JavaScript!
ABCB1/P-glycoprotein 1 in Human [ChEMBL: CHEMBL4302] [GtoPdb: 768] [UniProtKB: P08183] There should be some charts here, you may need to enable JavaScript!
Plasmodium falciparum [ChEMBL: CHEMBL364] There should be some charts here, you may need to enable JavaScript!
Protease in Human immunodeficiency virus 1 [ChEMBL: CHEMBL2366517] [UniProtKB: Q9YQ12] There should be some charts here, you may need to enable JavaScript!
Nav1.5/Sodium channel protein type V alpha subunit in Human [ChEMBL: CHEMBL1980] [GtoPdb: 582] [UniProtKB: Q14524] There should be some charts here, you may need to enable JavaScript!
Kv7.1/Voltage-gated potassium channel, IKs; KCNQ1(Kv7.1)/KCNE1(MinK) in Human [ChEMBL: CHEMBL2221347] [GtoPdb: 560] [UniProtKB: P15382, P51787] There should be some charts here, you may need to enable JavaScript!
Kv4.3/Voltage-gated potassium channel subunit Kv4.3 in Human [ChEMBL: CHEMBL1964] [GtoPdb: 554] [UniProtKB: Q9UK17] There should be some charts here, you may need to enable JavaScript!

DB	Assay description	Assay Type	Standard value	Standard parameter	Original value	Original units	Original parameter	Reference
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809]
ChEMBL	Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform	F	4	pIC50	100000	nM	IC50	J Pharmacol Toxicol Methods (2014) 70: 246-254 [PMID:25087753]
ChEMBL	Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform	F	4.2	pIC50	63095.73	nM	IC50	J Pharmacol Toxicol Methods (2014) 70: 246-254 [PMID:25087753]
Human immunodeficiency virus type 1 protease in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL243] [UniProtKB: Q72874]
ChEMBL	Inhibition of HIV1 protease V32I mutant by competitive binding	B	6.52	pKi	300	nM	Ki	J Med Chem (2008) 51: 6599-6603 [PMID:18808097]
ChEMBL	Inhibition of HIV1 protease V32I mutant by uncompetitive binding	B	6.74	pKi	180	nM	Ki	J Med Chem (2008) 51: 6599-6603 [PMID:18808097]
ChEMBL	Inhibition of HIV1 protease V32I mutant by enzyme inhibition	B	7.27	pKi	54	nM	Ki	J Med Chem (2008) 51: 6599-6603 [PMID:18808097]
ChEMBL	Binding affinity to HIV1 protease D30N	B	8.18	pKi	6.6	nM	Ki	J Med Chem (2006) 49: 1379-1387 [PMID:16480273]
ChEMBL	Inhibitory activity against HIV-1 protease	B	8.68	pKi	2.1	nM	Ki	Bioorg Med Chem Lett (1998) 8: 687-690 [PMID:9871583]
ChEMBL	Binding affinity to HIV1 protease I50V	B	8.7	pKi	2	nM	Ki	J Med Chem (2006) 49: 1379-1387 [PMID:16480273]
ChEMBL	Inhibition of HIV1 protease D30N mutant	B	8.72	pKi	1.9	nM	Ki	J Med Chem (2007) 50: 4509-4515 [PMID:17696515]
ChEMBL	Inhibition of HIV1 protease I50V mutant	B	8.89	pKi	1.3	nM	Ki	J Med Chem (2007) 50: 4509-4515 [PMID:17696515]
ChEMBL	Binding affinity to HIV1 protease I84V	B	8.96	pKi	1.1	nM	Ki	J Med Chem (2006) 49: 1379-1387 [PMID:16480273]
ChEMBL	Binding affinity to HIV1 protease V82A	B	9.1	pKi	0.8	nM	Ki	J Med Chem (2006) 49: 1379-1387 [PMID:16480273]
ChEMBL	Inhibition of HIV1 protease I84V mutant	B	9.25	pKi	0.56	nM	Ki	J Med Chem (2007) 50: 4509-4515 [PMID:17696515]
ChEMBL	Inhibition of HIV1 protease V82A mutant	B	9.27	pKi	0.54	nM	Ki	J Med Chem (2007) 50: 4509-4515 [PMID:17696515]
ChEMBL	Inhibition of wild type HIV1 protease expressed in Escherichia coli using Arg-Glu (EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition and measured for 10 mins by FRET assay	B	9.47	pKi	0.34	nM	Ki	ACS Med Chem Lett (2020) 11: 1196-1204 [PMID:32551001]
ChEMBL	Inhibition of HIV1 recombinant protease V32I/I47A mutant expressed in Escherichia coli by spectrophotometric assay	B	9.51	pKi	0.31	nM	Ki	J Med Chem (2008) 51: 4839-4843 [PMID:18598016]
ChEMBL	Binding affinity to HIV1 protease	B	9.66	pKi	0.22	nM	Ki	J Med Chem (2006) 49: 1379-1387 [PMID:16480273]
ChEMBL	Inhibition of wild type HIV1 protease using Arg-Glu (EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition and measured for 10 mins by FRET assay	B	9.74	pKi	0.18	nM	Ki	Eur J Med Chem (2021) 220: 113450-113450 [PMID:33906049]
ChEMBL	Inhibition of HIV1 recombinant protease M46I/A71V/V82T/I84V mutant expressed in Escherichia coli by spectrophotometric assay	B	10.49	pKi	0.03	nM	Ki	J Med Chem (2008) 51: 4839-4843 [PMID:18598016]
ChEMBL	Binding affinity to HIV1 protease L90M	B	10.52	pKi	0.03	nM	Ki	J Med Chem (2006) 49: 1379-1387 [PMID:16480273]
ChEMBL	Inhibition of HIV1 protease L10I, L63P, A71V, G73S, I84V, L90M mutant by FRET assay	B	10.57	pKi	0.03	nM	Ki	J Med Chem (2012) 55: 6328-6341 [PMID:22708897]
ChEMBL	Inhibition of HIV1 recombinant protease L10I/L24I/L33F/M46L/I54V/L63P/A71V/V82A/I84V mutant expressed in Escherichia coli by spectrophotometric assay	B	10.7	pKi	0.02	nM	Ki	J Med Chem (2008) 51: 4839-4843 [PMID:18598016]
ChEMBL	Inhibition of HIV-1 protease expressed in Escherichia coli assessed as inhibition constant using Ac-Thr-Ile-Met-Met-Gln-Arg as substrate preincubated for 10 mins followed by substrate addition by HPLC analysis	B	10.8	pKi	0.02	nM	Ki	Eur J Med Chem (2023) 255: 115385-115385 [PMID:37150084]
ChEMBL	Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELISA analysis	B	10.8	pKi	0.02	nM	Ki	Bioorg Med Chem Lett (2023) 83: 129168-129168 [PMID:36738797]
ChEMBL	Inhibitory activity against human immunodeficiency virus 1 protease	B	10.82	pKi	0.01	nM	Ki	J Med Chem (2005) 48: 3576-3585 [PMID:15887965]
ChEMBL	Inhibition of HIV1 recombinant protease L10I/I15V/E35D/N37S/R41K/I62V/L63P/A71V/G73S/L90M mutant expressed in Escherichia coli by spectrophotometric assay	B	10.82	pKi	0.01	nM	Ki	J Med Chem (2008) 51: 4839-4843 [PMID:18598016]
ChEMBL	Inhibition of HIV1 protease	B	10.85	pKi	0.01	nM	Ki	J Med Chem (2006) 49: 5252-5261 [PMID:16913714]
ChEMBL	Inhibition of HIV1 recombinant protease D30N/N88D mutant expressed in Escherichia coli by spectrophotometric assay	B	10.96	pKi	0.01	nM	Ki	J Med Chem (2008) 51: 4839-4843 [PMID:18598016]
ChEMBL	Inhibition of HIV-1 protease by fluorescence assay	B	11	pKi	0.01	nM	Ki	ACS Med Chem Lett (2023) 14: 171-175 [PMID:36793428]
ChEMBL	Inhibition of HIV-1 protease expressed in Escherichia coli using Arg-Glu-(EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys-(DABCTL)-Arg as substrate preincubated with compound for 20 to 30 mins followed by substrate addition and measured after 10 mins by FRET analysis	B	5.84	pIC50	1460	nM	IC50	Eur J Med Chem (2023) 246: 114981-114981 [PMID:36481598]
ChEMBL	Inhibition of HIV1 protease by FRET assay	B	6.43	pIC50	370	nM	IC50	Bioorg Med Chem Lett (2020) 30: 127019-127019 [PMID:32057582]
ChEMBL	Inhibition of HIV-1 protease expressed in Escherichia coli using Arg-Glu(EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition by FRET based assay	B	8.53	pIC50	2.92	nM	IC50	Bioorg Med Chem (2020) 28: 115623-115623 [PMID:32690263]
ChEMBL	Inhibition of recombinant HIV1 protease measured assessed as hydrolysis of fluorogenic substrate by FRET assay	B	8.76	pIC50	1.72	nM	IC50	Eur J Med Chem (2020) 186: 111900-111900 [PMID:31771827]
ChEMBL	Inhibition of wild type HIV1 protease expressed in Escherichia coli using Arg-Glu (EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition and measured for 10 mins by FRET assay	B	8.82	pIC50	1.52	nM	IC50	Eur J Med Chem (2021) 220: 113498-113498 [PMID:33933756]
ChEMBL	Inhibition of HIV-1 protease using Arg-Glu (EDANS)-Ser-Gln-Asn-Tyr-Pro-lle-Val-Gln-Lys (DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition and measured by FRET assay	B	8.93	pIC50	1.18	nM	IC50	Eur J Med Chem (2022) 233: 114251-114251 [PMID:35278855]
ChEMBL	Inhibition of HIV-1 protease by fluorescence resonance energy transfer analysis	B	9.06	pIC50	0.87	nM	IC50	Bioorg Med Chem Lett (2024) 101: 129651-129651 [PMID:38342391]
ChEMBL	Inhibition of HIV1 protease expressed in Escherichia coli using Arg-Glu (EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition and measured for 10 mins by FRET assay	B	9.29	pIC50	0.51	nM	IC50	Bioorg Med Chem (2022) 64: 116760-116760 [PMID:35483138]
ABCB1/P-glycoprotein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4302] [GtoPdb: 768] [UniProtKB: P08183]
ChEMBL	Inhibition of human MDR1-dependent accumulation of calcein-AM expressed in MDCK2 cells	B	4	pIC50	>100000	nM	IC50	Antimicrob Agents Chemother (2007) 51: 3498-3504 [PMID:17664327]
ChEMBL	Inhibition of P-gp in human 12D7-MDR cells using NBD-Aba as substrate after 30 mins by flow cytometric analysis	B	4.22	pIC50	60000	nM	IC50	J Med Chem (2020) 63: 2131-2138 [PMID:31505928]
ChEMBL	Inhibition of P-gp in human 12D7-MDR cells using calcein-AM as substrate after 30 mins by flow cytometric analysis	B	4.48	pIC50	33200	nM	IC50	J Med Chem (2020) 63: 2131-2138 [PMID:31505928]
ChEMBL	Inhibition of P-gp in human CMEC/D3 cells using NBD-Aba as substrate after 30 mins by flow cytometric analysis	B	4.81	pIC50	15400	nM	IC50	J Med Chem (2020) 63: 2131-2138 [PMID:31505928]
ChEMBL	Inhibition of P-gp in human CMEC/D3 cells using calcein-AM as substrate after 30 mins by flow cytometric analysis	B	5.18	pIC50	6600	nM	IC50	J Med Chem (2020) 63: 2131-2138 [PMID:31505928]
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364]
ChEMBL	DNDI: Malaria in Vitro, 72 hour	F	4.33	pIC50	46930	nM	IC50	Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
ChEMBL	Antimicrobial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 48 hrs	F	4.15	pEC50	70000	nM	EC50	Antimicrob Agents Chemother (2010) 54: 1334-1337 [PMID:20028821]
Protease in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2366517] [UniProtKB: Q9YQ12]
ChEMBL	Binding affinity to HIV1 protease	B	10.8	pKd	0.02	nM	Kd	J Med Chem (2016) 59: 4171-4188 [PMID:26356253]
ChEMBL	Inhibition of wild type HIV1 protease by competitive binding	B	7.66	pKi	22	nM	Ki	J Med Chem (2008) 51: 6599-6603 [PMID:18808097]
ChEMBL	Inhibition of wild type HIV1 protease by uncompetitive binding	B	7.74	pKi	18	nM	Ki	J Med Chem (2008) 51: 6599-6603 [PMID:18808097]
ChEMBL	Inhibition of wild type HIV1 protease by enzyme inhibition	B	8.05	pKi	9	nM	Ki	J Med Chem (2008) 51: 6599-6603 [PMID:18808097]
ChEMBL	Inhibition of HIV1 protease expressed in Escherichia coli by fluorometric assay	B	8.96	pKi	1.1	nM	Ki	J Med Chem (2010) 53: 607-615 [PMID:19961222]
ChEMBL	Inhibition of HIV1 recombinant protease using Lys-Ala-Arg-Val-Nle-Nph-Glu-Ala-Nle-NH2 as substrate by spectrophotometric analysis	B	9.3	pKi	0.5	nM	Ki	J Med Chem (2012) 55: 5784-5796 [PMID:22621689]
ChEMBL	Inhibition of wild type HIV1 protease	B	9.47	pKi	0.34	nM	Ki	J Med Chem (2007) 50: 4509-4515 [PMID:17696515]
ChEMBL	Binding affinity to HIV1 protease I50V mutant	B	9.48	pKi	0.33	nM	Ki	J Med Chem (2016) 59: 2849-2878 [PMID:26509831]
ChEMBL	Inhibition of HIV1 NL4-3 protease I50V/A71V mutant expressed in Escherichia coli TAP-106 cells using EDANS/DABCYL-labelled 10-amino acid containing protease cleavage site as substrate preincubated for 1 hr followed by substrate addition and measured for 60 mins by FRET assay	B	10.12	pKi	0.07	nM	Ki	J Med Chem (2020) 63: 8296-8313 [PMID:32672965]
ChEMBL	Inhibition of HIV1 NL4-3 protease I50V/A71V mutant expressed in Escherichia coli TAP-106 cells using EDANS/DABCYL-labelled 10-amino acid containing natural MA/CA cleavage site as substrate preincubated for 1 hr followed by substrate addition and measured for 60 mins by FRET assay	B	10.12	pKi	0.07	nM	Ki	J Med Chem (2019) 62: 8062-8079 [PMID:31386368]
ChEMBL	Binding affinity to HIV1 protease D30N mutant	B	10.39	pKi	0.04	nM	Ki	J Med Chem (2016) 59: 2849-2878 [PMID:26509831]
ChEMBL	Binding affinity to HIV1 protease N88D mutant	B	10.39	pKi	0.04	nM	Ki	J Med Chem (2016) 59: 2849-2878 [PMID:26509831]
ChEMBL	Binding affinity to HIV1 protease A71V mutant	B	10.6	pKi	0.03	nM	Ki	J Med Chem (2016) 59: 2849-2878 [PMID:26509831]
ChEMBL	Inhibition of HIV1 NL4-3 protease I84V mutant expressed in Escherichia coli TAP-106 cells using EDANS/DABCYL-labelled 10-amino acid containing natural MA/CA cleavage site as substrate preincubated for 1 hr followed by substrate addition and measured for 60 mins by FRET assay	B	10.6	pKi	0.03	nM	Ki	J Med Chem (2019) 62: 8062-8079 [PMID:31386368]
ChEMBL	Binding affinity to HIV1 protease G73S mutant	B	10.6	pKi	0.03	nM	Ki	J Med Chem (2016) 59: 2849-2878 [PMID:26509831]
ChEMBL	Inhibition of HIV1 NL4-3 protease I84V mutant expressed in Escherichia coli TAP-106 cells using EDANS/DABCYL-labelled 10-amino acid containing protease cleavage site as substrate preincubated for 1 hr followed by substrate addition and measured for 60 mins by FRET assay	B	10.6	pKi	0.03	nM	Ki	J Med Chem (2020) 63: 8296-8313 [PMID:32672965]
ChEMBL	Binding affinity to HIV1 protease I84V mutant	B	10.6	pKi	0.03	nM	Ki	J Med Chem (2016) 59: 2849-2878 [PMID:26509831]
ChEMBL	Binding affinity to HIV1 protease L90M mutant	B	10.6	pKi	0.03	nM	Ki	J Med Chem (2016) 59: 2849-2878 [PMID:26509831]
ChEMBL	Inhibition of wild type HIV-1 NL4-3 protease expressed in Escherichia coli Rosetta (DE3)pLysS using Ac-Thr-Ile-Nle-Nle-Gln-Arg-NH2 as substrate by fluorescence assay	B	10.8	pKi	0.02	nM	Ki	J Med Chem (2018) 61: 4561-4577 [PMID:29763303]
ChEMBL	Inhibition of HIV1 wild type NL4-3 protease expressed in Escherichia coli Rosetta (DE3) pLysS using Abz-Thr-Ile-Nle-Phe-(pNO2)-Gln-Arg-NH2 as substrate preincubated for 5 to 10 mins followed by substrate addition measured after 1 hr by fluorescence assay	B	10.8	pKi	0.02	nM	Ki	J Med Chem (2018) 61: 9722-9737 [PMID:30354121]
ChEMBL	Inhibition of HIV1 protease	B	10.8	pKi	0.02	nM	Ki	Bioorg Med Chem (2007) 15: 7576-7580 [PMID:17900913]
ChEMBL	Inhibition of HIV1 protease using Ac-Thr-Ile-Nle-Nle-Gln-Arg-NH2 substrate by continuous fluorometric assay	B	10.8	pKi	0.02	nM	Ki	Bioorg Med Chem Lett (2019) 29: 2565-2570 [PMID:31416666]
ChEMBL	Inhibition of HIV-1 protease	B	10.8	pKi	0.02	nM	Ki	J Med Chem (2020) 63: 4867-4879 [PMID:32348139]
ChEMBL	Inhibition of HIV1 protease	B	10.8	pKi	0.02	nM	Ki	J Med Chem (2009) 52: 7689-7705 [PMID:19746963]
ChEMBL	Inhibition of HIV1 protease	B	10.8	pKi	0.02	nM	Ki	Bioorg Med Chem Lett (2010) 20: 1241-1246 [PMID:20034787]
ChEMBL	Inhibition of HIV1 protease	B	10.8	pKi	0.02	nM	Ki	J Med Chem (2012) 55: 3387-3397 [PMID:22401672]
ChEMBL	Inhibition of HIV1 protease	B	10.8	pKi	0.02	nM	Ki	J Med Chem (2008) 51: 6021-6033 [PMID:18783203]
ChEMBL	Inhibition of HIV1 protease	B	10.8	pKi	0.02	nM	Ki	J Med Chem (2012) 55: 5784-5796 [PMID:22621689]
ChEMBL	Inhibition of HIV1 protease	B	10.8	pKi	0.02	nM	Ki	J Med Chem (2015) 58: 6994-7006 [PMID:26306007]
ChEMBL	Inhibition of HIV-1 protease by fluorometric assay	B	10.8	pKi	0.02	nM	Ki	Bioorg Med Chem Lett (2015) 25: 4903-4909 [PMID:26096678]
ChEMBL	Inhibition of HIV1 protease dimerization in MT2 cells	B	10.8	pKi	0.02	nM	Ki	J Biol Chem (2007) 282: 28709-28720 [PMID:17635930]
ChEMBL	Inhibition of HIV1 protease	B	10.85	pKi	0.01	nM	Ki	J Med Chem (2009) 52: 2163-2176 [PMID:19323561]
ChEMBL	Inhibition of HIV1 protease using RE(Edans)SGIFLETSK(Dabcyl)R as substrate by fluorescence method	B	11	pKi	0.01	nM	Ki	J Med Chem (2019) 62: 9375-9414 [PMID:31050421]
ChEMBL	Inhibition of wild type HIV1 protease expressed in Escherichia coli using Arg-Glu (EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition and measured for 10 mins by FRET assay	B	8.4	pIC50	4.01	nM	IC50	Bioorg Med Chem Lett (2019) 29: 1541-1545 [PMID:31014912]
ChEMBL	Inhibition of Human immunodeficiency virus 1 3B protease	B	8.42	pIC50	3.8	nM	IC50	ACS Med Chem Lett (2011) 2: 461-465 [PMID:24900331]
ChEMBL	Inhibition of HIV1 protease expressed in Escherichia coli using Arg-Glu (EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition and measured for 10 mins by FRET assay	B	8.95	pIC50	1.12	nM	IC50	Eur J Med Chem (2020) 185: 111866-111866 [PMID:31734023]
ChEMBL	Inhibition of HIV1 protease expressed in Escherichia coli using Arg-Glu (EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition and measured for 10 mins by FRET assay	B	9.34	pIC50	0.46	nM	IC50	Bioorg Med Chem Lett (2019) 29: 357-361 [PMID:30580917]
ChEMBL	Inhibition of HIV1 protease expressed in Escherichia coli incubated for 20 to 30 mins at room temperature using (Arg-Glu(EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg) substrate by FRET method	B	10.21	pIC50	0.06	nM	IC50	Bioorg Med Chem Lett (2015) 25: 1880-1883 [PMID:25838144]
ChEMBL	Inhibition of HIV1 protease expressed in Escherichia coli using Arg-Glu (EDANS)-Ser-GlnAsn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition measured for 10 mins by FRET method	B	10.22	pIC50	0.06	nM	IC50	Eur J Med Chem (2017) 137: 30-44 [PMID:28554091]
ChEMBL	Inhibition of HIV1 protease expressed in Escherichia coli using Val-Ser-Gln-Asn-(beta-naphtyl)Ala-Pro-Ile-Val as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by mass spectrometric method	B	10.89	pIC50	0.01	nM	IC50	ACS Med Chem Lett (2017) 8: 1292-1297 [PMID:29259750]
ChEMBL	Inhibition of DRV-resistant protease V32I/L33F/I54M/I84V mutant in HIV1 transfected in 293T cells after 48 hrs by lentiviral vector-based luciferase reporter gene assay	B	6.95	pEC50	112.08	nM	EC50	J Med Chem (2018) 61: 5138-5153 [PMID:29852069]
ChEMBL	Inhibition of DRV-resistant protease V32I/L33F/I54M/V82I mutant in HIV1 transfected in 293T cells after 48 hrs by lentiviral vector-based luciferase reporter gene assay	B	7.9	pEC50	12.66	nM	EC50	J Med Chem (2018) 61: 5138-5153 [PMID:29852069]
Nav1.5/Sodium channel protein type V alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1980] [GtoPdb: 582] [UniProtKB: Q14524]
ChEMBL	Inhibition of fast sodium current (INa) in HEK293 cells transfected with human Nav1.5 measured using IonWorks Quattro automated patch clamp platform	F	4	pIC50	100000	nM	IC50	J Pharmacol Toxicol Methods (2014) 70: 246-254 [PMID:25087753]
ChEMBL	Inhibition of fast sodium current (INa) in Chinese Hamster Ovary (CHO) K1 cells transfected with human Nav1.5 measured using IonWorks Quattro automated patch clamp platform	F	4.4	pIC50	39810.72	nM	IC50	J Pharmacol Toxicol Methods (2014) 70: 246-254 [PMID:25087753]
Kv7.1/Voltage-gated potassium channel, IKs; KCNQ1(Kv7.1)/KCNE1(MinK) in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2221347] [GtoPdb: 560] [UniProtKB: P15382, P51787]
ChEMBL	Inhibition of slow delayed inward rectifying potassium current (Iks) in Chinese Hamster Ovary (CHO) cells transfected with KCNQ1 / Kv1.7 / KvLQT1 and KCNE1/minK measured using IonWorks automated patch clamp platform	F	4.3	pIC50	50118.72	nM	IC50	J Pharmacol Toxicol Methods (2014) 70: 246-254 [PMID:25087753]
Kv4.3/Voltage-gated potassium channel subunit Kv4.3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1964] [GtoPdb: 554] [UniProtKB: Q9UK17]
ChEMBL	Inhibition of transient outward potassium current (Ito) current in Chinese Hamster Ovary (CHO) K1 cells expressing human Kv4.3 measured using IonWorks Quattro automated patch clamp platform	F	4	pIC50	100000	nM	IC50	J Pharmacol Toxicol Methods (2014) 70: 246-254 [PMID:25087753]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]